VINDESINE SULFATE

DRUG4 trials

Sponsors

Medical University Of Silesia Katowice Poland, University Of Cologne, Medical University Of Lodz, University Hospital Muenster

Conditions

Acute lymphoblastic leukemiaMature B-cell Non-Hodgkin Lymphomalow and intermediate risk neuroblastoma

Phase 2

Ruxolitinib for childhood ALL in Poland (Rux-cALL-Pol 2020 trial) - Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.

Not yet recruitingCTIS2024-518316-39-00

Medical University Of LodzAcute lymphoblastic leukemia

Target: 25Updated: 2025-04-04

Phase 3

Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents

Active, not recruitingNCT03206671

University Hospital MuensterMature B-cell Non-Hodgkin Lymphoma

Start: 2017-08-03End: 2027-06-30Target: 650Updated: 2025-03-24

Prospective multicenter clinical trial for risk estimation and treatment stratification in low and intermediate risk neuroblastoma patients - NB2015-LR

Not yet recruitingCTIS2024-517295-37-00

University Of Colognelow and intermediate risk neuroblastoma

Target: 280Updated: 2024-10-25

Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia. A randomized phase III study conducted in agreement with the AIEOP-BFM study group.

Active, not recruitingCTIS2024-517253-27-00

Medical University Of Silesia Katowice PolandAcute lymphoblastic leukemia

Start: 2021-07-01Target: 874Updated: 2024-10-28